PMV Pharmaceuticals, Inc. — Director's Dealing 2022

Jun 6, 2022

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: PMV Pharmaceuticals, Inc. (PMVP)
CIK: 0001699382
Period of Report: 2022-06-02

Reporting Person: BAUM CHARLES M (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2022-06-02	Stock Option (right to buy)	$13.56	A	19500	Acquired	2032-06-01	Common Stock (19500)	Direct

Footnotes

F1: Shares subject to the option vest on the earlier of (i) June 2, 2023 or (ii) the day prior to the date of the Issuer's next annual meeting of stockholders